Jan Makela - Jan 3, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Imaging
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 07:47 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common stock, par value $0.01 per share Award +32 32 Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +1.47K 1.47K Jan 4, 2023 Common stock, par value $0.01 per share 1.47K $129.52 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +206 206 Jan 4, 2023 Common stock, par value $0.01 per share 206 $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +2.33K 2.33K Jan 4, 2023 Common stock, par value $0.01 per share 2.33K $142.15 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4.41K 4.41K Jan 4, 2023 Common stock, par value $0.01 per share 4.41K $135.92 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +7.35K 7.35K Jan 4, 2023 Common stock, par value $0.01 per share 7.35K $161.30 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +54.7K 54.7K Jan 4, 2023 Common stock, par value $0.01 per share 54.7K $40.40 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +5.97K 5.97K Jan 4, 2023 Common stock, par value $0.01 per share 5.97K $57.74 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +4.04K 4.04K Jan 4, 2023 Common stock, par value $0.01 per share 4.04K $51.67 Direct F1, F2
transaction GEHC Employee Stock Option (right to buy) Award +240 240 Jan 4, 2023 Common stock, par value $0.01 per share 240 $63.51 Direct F1, F3
transaction GEHC Employee Stock Option (right to buy) Award +28.6K 28.6K Jan 4, 2023 Common stock, par value $0.01 per share 28.6K $63.51 Direct F1, F3
transaction GEHC Employee Stock Option (right to buy) Award +66.2K 66.2K Jan 4, 2023 Common stock, par value $0.01 per share 66.2K $76.37 Direct F1, F4
transaction GEHC Restricted Stock Units Award +3.24K 3.24K Jan 4, 2023 Common stock, par value $0.01 per share 3.24K Direct F1, F5, F6
transaction GEHC Restricted Stock Units Award +19.6K 19.6K Jan 4, 2023 Common stock, par value $0.01 per share 19.6K Direct F1, F5, F7
transaction GEHC Restricted Stock Units Award +14.8K 14.8K Jan 4, 2023 Common stock, par value $0.01 per share 14.8K Direct F1, F5, F8
transaction GEHC Restricted Stock Units Award +8.21K 8.21K Jan 4, 2023 Common stock, par value $0.01 per share 8.21K Direct F1, F5, F9
transaction GEHC Restricted Stock Units Award +14.6K 14.6K Jan 4, 2023 Common stock, par value $0.01 per share 14.6K Direct F1, F5, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
F2 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
F3 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.
F4 Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.
F5 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F6 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
F7 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.
F8 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
F9 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024.
F10 Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.